Leal Therapeutics

Leal Therapeutics is a biotechnology company developing novel therapeutics for patients with central nervous system (CNS) disorders. Their lead programs focus on antisense oligonucleotide (ASO) and small molecule therapeutics targeting metabolic pathways dysregulated in ALS and schizophrenia. The company aims to provide better treatment options for neurodegenerative and neuropsychiatric disorders.

Buy Funded Startups lists

Funding Round:

Funding Amount: $45M

Date: 30-Oct-2024

Investors: Newpath Partners, Chugai Venture Fund, Alexandria Venture Investments, OrbiMed, Euclidean Capital, PhiFund

Markets: Biotechnology, Pharmaceuticals, Healthtech

HQ: Worcester, Massachusetts, United States

Founded: 2021

Website: https://lealtx.com/

LinkedIn: https://www.linkedin.com/company/leal-therapeutics

Twitter:

Instagram: